Institute News: Announcements

The promise of gene therapy

by Robert Desimone |

Portrait of Bob Desimone wearing a suit and tie.
McGovern Institute Director Robert Desimone. Photo: Steph Stevens

As we start 2024, I hope you can join me in celebrating a historic recent advance: the FDA approval of Casgevy, a bold new treatment for devastating sickle cell disease and the world’s first approved CRISPR gene therapy.

Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, we are proud to share that this pioneering therapy licenses the CRISPR discoveries of McGovern scientist and Poitras Professor of Neuroscience Feng Zhang.

It is amazing to think that Feng’s breakthrough work adapting CRISPR-Cas9 for genome editing in eukaryotic cells was published only 11 years ago today in Science.

Incredibly, CRISPR-Cas9 rapidly transitioned from proof-of-concept experiments to an approved treatment in just over a decade.

McGovern scientists are determined to maintain the momentum!

 

Incredibly, CRISPR-Cas9 rapidly transitioned from proof-of-concept experiments to an approved treatment in just over a decade.

Our labs are creating new gene therapies that are already in clinical trials or preparing to enroll patients in trials. For instance, Feng Zhang’s team has developed therapies currently in clinical trials for lymphoblastic leukemia and beta thalassemia, while another McGovern researcher, Guoping Feng, the Poitras Professor of Brain and Cognitive Sciences at MIT, has made advancements that lay the groundwork for a new gene therapy to treat a severe form of autism spectrum disorder. It is expected to enter clinical trials later this year. Moreover, McGovern fellows Omar Abudayyeh and Jonathan Gootenberg created programmable genomic tools that are now licensed for use in monogenic liver diseases and autoimmune disorders.

These exciting innovations stem from your steadfast support of our high-risk, high-reward research. Your generosity is enabling our scientists to pursue basic research in other areas with potential therapeutic applications in the future, such as mechanisms of pain, addiction, the connections between the brain and gut, the workings of memory and attention, and the bi-directional influence of artificial intelligence on brain research. All of this fundamental research is being fueled by major new advances in technology, many of them developed here.

As we enter a new year filled with anticipation following our inaugural gene therapy, I want to express my heartfelt gratitude for your invaluable support in advancing our research programs. Your role in pushing our research to new heights is valued by all faculty, students, and researchers at the McGovern Institute. We can’t wait to share our continued progress with you.

Thank you again for partnering with us to make great scientific achievements possible.

With appreciation and best wishes,

Robert Desimone, PhD
Director, McGovern Institute
Doris and Don Berkey Professor of Neuroscience, MIT

Season’s Greetings from the McGovern Institute

by McGovern Institute |

This year’s holiday greeting (video above) was inspired by research conducted in John Gabrieli’s lab, which found that practicing mindfulness reduced children’s stress levels and negative emotions during the pandemic. These findings contribute to a growing body of evidence that practicing mindfulness can change patterns of brain activity associated with emotions and mental health.

Coloring is one form of mindfulness, or focusing awareness on the present. Visit our postcard collection to download and color your own brain-themed postcards and may the spirit of mindfulness bring you peace in the year ahead!

Video credits:
Joseph Laney (illustration)
JR Narrows, Space Lute (sound design)
Jacob Pryor (animation)

A mindful McGovern community

by Julie Pryor |

Mindfulness is the practice of maintaining a state of complete awareness of one’s thoughts, emotions, or experiences on a moment-to-moment basis. McGovern researchers have shown that practicing mindfulness reduces anxiety and supports emotional resilience.

In a survey distributed to the McGovern Institute community, 57% of the 74 researchers, faculty, and staff who responded, said that they practice mindfulness as a way to reduce anxiety and stress.

Here are a few of their stories.

Fernanda De La Torre

Portrait of a smiling woman leaning back against a railing.
MIT graduate student Fernanda De La Torre. Photo: Steph Stevens

Fernanda De La Torre is a graduate student in MIT’s Department of Brain and Cognitive Sciences, where she is advised by Josh McDermott.

Originally from Mexico, De La Torre took an unconventional path to her education in the United States, where she completed her undergraduate studies in computer science and math at Kansas State University. In 2019, she came to MIT as a postbaccalaureate student in the lab of Tomaso Poggio where she began working on deep-learning theory, an area of machine learning focused on how artificial neural networks modeled on the brain can learn to recognize patterns and learn.

A recent recipient of the prestigious Paul and Daisy Soros Fellowship for New Americans, De La Torre now studies multisensory integration during speech perception using deep learning models in Josh McDermott’s lab.

What kind of mindfulness do you practice, how often, and why?

Metta meditation is the type of meditation I come back to the most. I practice 2-3 times per week. Sometimes by joining Nikki Mirghafori’s Zoom calls or listening to her and other teachers’ recordings on AudioDharma. I practice because when I observe the patterns of my thoughts, I remember the importance of compassion, including self-compassion. In my experience, I find metta meditation is a wonderful way to cultivate the two: observation and compassion. 

When and why did you start practicing mindfulness?

My first meditation practice was as a first-year post-baccalaureate student here at BCS. Gal Raz (also pictured above) carried a lot of peace and attributed it to meditation; this sparked my curiosity. I started practicing more frequently last summer, after realizing my mental health was not in a good place.

How does mindfulness benefit your research at MIT?

This is hard to answer because I think the benefits of meditation are hard to measure. I find that meditation helps me stay centered and healthy, which can indirectly help the research I do. More directly, some of my initial grad school pursuits were fueled by thoughts during meditation but I ended up feeling that a lot of these concepts are hard to explore using non-philosophical approaches. So I think meditation is mainly a practice that helps my health, my relationships with others, and my relationship with work (this last one I find most challenging and personally unresolved). 

Adam Eisen

MIT graduate student Adam Eisen.

Adam Eisen is a graduate student in MIT’s Department of Brain and Cognitive Sciences, where he is co-advised by Ila Fiete (McGovern Institute) and Earl Miller (Picower Institute).

Eisen completed his undergraduate degree in Applied Mathematics & Computer Engineering at Queen’s University in Toronto, Canada. Prior to joining MIT, Eisen built computer vision algorithms at the solar aerial inspection company Heliolytics and worked on developing machine learning tools to predict disease outcomes from genetics at The Hospital for Sick Children.

Today, in the Fiete and Miller labs, Eisen develops tools for analyzing the flow of neural activity, and applies them to understand changes in neural states (such as from consciousness to anesthetic-induced unconsciousness).

What kind of mindfulness do you practice, how often, and why?

I mostly practice simple sitting meditation centered on awareness of senses and breathing. On a good week, I meditate about 3-5 times. The reason I practice are the benefits to my general experience of living. Whenever I’m in a prolonged period of consistent meditation, I’m shocked by how much more awareness I have about thoughts, feelings and sensations that are arising in my mind throughout the day. I’m also amazed by how much easier it is to watch my mind and body react to the context around me, without slipping into the usual patterns and habits. I also find mindful benefits in doing yoga, running and playing music, but the core is really centered on meditation practice.

When and why did you start practicing mindfulness?

I’ve been interested in mindfulness and meditation since undergrad as a path to investigating the nature of mind and thought – an interest which also led me into my PhD. I started practicing meditation more seriously at the start of the pandemic to get more first hand experience with what I had been learning about. I find meditation is one of those things where knowledge and theory can support the practice, but without the experiential component it’s very hard to really start to build an understanding of the core concepts at play.

How does mindfulness benefit your research at MIT?

Mindfulness has definitely informed the kinds of things I’m interested in studying and the questions I’d like to ask – largely in relation to the nature of conscious awareness and the flow of thoughts. Outside of that, I’d like to think that mindfulness benefits my general well-being and spiritual balance, which enables me to do better research.

 

Sugandha Sharma

Woman clasping hands in a yoga pose, looking directly into the camera.
MIT graduate student Sugandha Sharma. Photo: Steph Stevens

Sugandha (Su) Sharma is a graduate student in MIT’s Department of Brain and Cognitive Sciences (BCS), where she is co-advised by Ila Fiete (McGovern Institute) and Josh Tenenbaum (BCS).

Prior to joining MIT, she studied theoretical neuroscience at the University of Waterloo where she built neural models of context dependent decision making in the prefrontal cortex and spiking neuron models of bayesian inference, based on online learning of priors from life experience.

Today, in the Fiete and Tenenbaum labs, she studies the computational and theoretical principles underlying cognition and intelligence in the human brain.  She is currently exploring the coding principles in the hippocampal circuits implicated in spatial navigation, and their role in cognitive computations like structure learning and relational reasoning.

When did you start practicing mindfulness?

When I first learned to meditate, I was challenged to practice it every day for at least 3 months in a row. I took up the challenge, and by the end of it, the results were profound. My whole perspective towards life changed. It made me more empathetic — I could step in other people’s shoes and be mindful of their situations and feelings;  my focus shifted from myself to the big picture — it made me realize how insignificant my life was on the grand scale of the universe, and how it was worthless to be caught up in small things that I was usually worrying about. It somehow also brought selflessness to me. This experience hooked me to meditation and mindfulness for life!

What kind of mindfulness do you practice and why?

I practice mindfulness because it brings awareness. It helps me to be aware of myself, my thoughts, my actions, and my surroundings at each moment in my life, thus helping me stay in and enjoy the present moment. Awareness is of utmost importance since an aware mind always does the right thing. Imagine that you are angry, in that moment you have lost awareness of yourself. The moment you become aware of yourself; anger goes away. This is why sometimes counting helps to combat anger. If you start counting, that gives you time to think and become aware of yourself and your actions.

Meditating — sitting with my eyes closed and just observing (being aware of) my thoughts — is a yogic technique that helps me clear the noise in my mind and calm it down making it easier for me to be mindful not only while meditating, but also in general after I am done meditating. Over time, the thoughts vanish, and the mind becomes blank (noiseless). For this reason, practicing meditation regularly makes it easier for me to be mindful all the time.

An added advantage of yoga and meditation is that it helps combat stress by relaxing the mind and body. Many people don’t know what to do when they are stressed, but I am grateful to have this toolkit of yoga and meditation to deal with stressful situations in my life. They help me calm my mind in stressful situations and ensure that instead of reacting to a situation, I instead act mindfully and appropriately to make it right.

K. Lisa Yang Postbaccalaureate Program names new scholars

by Julie Pryor |

Funded by philanthropist Lisa Yang, the K. Lisa Yang Postbaccalaureate Scholar Program provides two years of paid laboratory experience, mentorship, and education to recent college graduates from backgrounds underrepresented in neuroscience. This year, two young researchers in McGovern Institute labs, Joseph Itiat and Sam Merrow, are the recipients of the Yang postbac program.

Itiat moved to the United States from Nigeria in 2019 to pursue a degree in psychology and cognitive neuroscience at Temple University. Today, he is a Yang postbac in John Gabrieli’s lab studying the relationship between learning and value processes and their influence on future-oriented decision-making. Ultimately, Itiat hopes to develop models that map the underlying mechanisms driving these processes.

“Being African, with limited research experience and little representation in the domain of neuroscience research,” Itiat says, “I chose to pursue a postbaccalaureate
research program to prepare me for a top graduate school and a career in cognitive neuroscience.”

Merrow first fell in love with science while working at the Barrow Neurological Institute in Arizona during high school. After graduating from Simmons University in Boston, Massachusetts, Merrow joined Guoping Feng’s lab as a Yang postbac to pursue research on glial cells and brain disorders. “As a queer, nonbinary, LatinX person, I have not met anyone like me in my field, nor have I had role models that hold a similar identity to myself,” says Merrow.

“My dream is to one day become a professor, where I will be able to show others that science is for anyone.”

Previous Yang postbacs include Alex Negron, Zoe Pearce, Ajani Stewart, and Maya Taliaferro.

What does the future hold for generative AI?

by Adam Zewe |

Speaking at the “Generative AI: Shaping the Future” symposium on Nov. 28, the kickoff event of MIT’s Generative AI Week, keynote speaker and iRobot co-founder Rodney Brooks warned attendees against uncritically overestimating the capabilities of this emerging technology, which underpins increasingly powerful tools like OpenAI’s ChatGPT and Google’s Bard.

“Hype leads to hubris, and hubris leads to conceit, and conceit leads to failure,” cautioned Brooks, who is also a professor emeritus at MIT, a former director of the Computer Science and Artificial Intelligence Laboratory (CSAIL), and founder of Robust.AI.

“No one technology has ever surpassed everything else,” he added.

The symposium, which drew hundreds of attendees from academia and industry to the Institute’s Kresge Auditorium, was laced with messages of hope about the opportunities generative AI offers for making the world a better place, including through art and creativity, interspersed with cautionary tales about what could go wrong if these AI tools are not developed responsibly.

Generative AI is a term to describe machine-learning models that learn to generate new material that looks like the data they were trained on. These models have exhibited some incredible capabilities, such as the ability to produce human-like creative writing, translate languages, generate functional computer code, or craft realistic images from text prompts.

In her opening remarks to launch the symposium, MIT President Sally Kornbluth highlighted several projects faculty and students have undertaken to use generative AI to make a positive impact in the world. For example, the work of the Axim Collaborative, an online education initiative launched by MIT and Harvard, includes exploring the educational aspects of generative AI to help underserved students.

The Institute also recently announced seed grants for 27 interdisciplinary faculty research projects centered on how AI will transform people’s lives across society.

In hosting Generative AI Week, MIT hopes to not only showcase this type of innovation, but also generate “collaborative collisions” among attendees, Kornbluth said.

Collaboration involving academics, policymakers, and industry will be critical if we are to safely integrate a rapidly evolving technology like generative AI in ways that are humane and help humans solve problems, she told the audience.

“I honestly cannot think of a challenge more closely aligned with MIT’s mission. It is a profound responsibility, but I have every confidence that we can face it, if we face it head on and if we face it as a community,” she said.

While generative AI holds the potential to help solve some of the planet’s most pressing problems, the emergence of these powerful machine learning models has blurred the distinction between science fiction and reality, said CSAIL Director Daniela Rus in her opening remarks. It is no longer a question of whether we can make machines that produce new content, she said, but how we can use these tools to enhance businesses and ensure sustainability. 

“Today, we will discuss the possibility of a future where generative AI does not just exist as a technological marvel, but stands as a source of hope and a force for good,” said Rus, who is also the Andrew and Erna Viterbi Professor in the Department of Electrical Engineering and Computer Science.

But before the discussion dove deeply into the capabilities of generative AI, attendees were first asked to ponder their humanity, as MIT Professor Joshua Bennett read an original poem.

Bennett, a professor in the MIT Literature Section and Distinguished Chair of the Humanities, was asked to write a poem about what it means to be human, and drew inspiration from his daughter, who was born three weeks ago.

The poem told of his experiences as a boy watching Star Trek with his father and touched on the importance of passing traditions down to the next generation.

In his keynote remarks, Brooks set out to unpack some of the deep, scientific questions surrounding generative AI, as well as explore what the technology can tell us about ourselves.

To begin, he sought to dispel some of the mystery swirling around generative AI tools like ChatGPT by explaining the basics of how this large language model works. ChatGPT, for instance, generates text one word at a time by determining what the next word should be in the context of what it has already written. While a human might write a story by thinking about entire phrases, ChatGPT only focuses on the next word, Brooks explained.

ChatGPT 3.5 is built on a machine-learning model that has 175 billion parameters and has been exposed to billions of pages of text on the web during training. (The newest iteration, ChatGPT 4, is even larger.) It learns correlations between words in this massive corpus of text and uses this knowledge to propose what word might come next when given a prompt.

The model has demonstrated some incredible capabilities, such as the ability to write a sonnet about robots in the style of Shakespeare’s famous Sonnet 18. During his talk, Brooks showcased the sonnet he asked ChatGPT to write side-by-side with his own sonnet.

But while researchers still don’t fully understand exactly how these models work, Brooks assured the audience that generative AI’s seemingly incredible capabilities are not magic, and it doesn’t mean these models can do anything.

His biggest fears about generative AI don’t revolve around models that could someday surpass human intelligence. Rather, he is most worried about researchers who may throw away decades of excellent work that was nearing a breakthrough, just to jump on shiny new advancements in generative AI; venture capital firms that blindly swarm toward technologies that can yield the highest margins; or the possibility that a whole generation of engineers will forget about other forms of software and AI.

At the end of the day, those who believe generative AI can solve the world’s problems and those who believe it will only generate new problems have at least one thing in common: Both groups tend to overestimate the technology, he said.

“What is the conceit with generative AI? The conceit is that it is somehow going to lead to artificial general intelligence. By itself, it is not,” Brooks said.

Following Brooks’ presentation, a group of MIT faculty spoke about their work using generative AI and participated in a panel discussion about future advances, important but underexplored research topics, and the challenges of AI regulation and policy.

The panel consisted of Jacob Andreas, an associate professor in the MIT Department of Electrical Engineering and Computer Science (EECS) and a member of CSAIL; Antonio Torralba, the Delta Electronics Professor of EECS and a member of CSAIL; Ev Fedorenko, an associate professor of brain and cognitive sciences and an investigator at the McGovern Institute for Brain Research at MIT; and Armando Solar-Lezama, a Distinguished Professor of Computing and associate director of CSAIL. It was moderated by William T. Freeman, the Thomas and Gerd Perkins Professor of EECS and a member of CSAIL.

The panelists discussed several potential future research directions around generative AI, including the possibility of integrating perceptual systems, drawing on human senses like touch and smell, rather than focusing primarily on language and images. The researchers also spoke about the importance of engaging with policymakers and the public to ensure generative AI tools are produced and deployed responsibly.

“One of the big risks with generative AI today is the risk of digital snake oil. There is a big risk of a lot of products going out that claim to do miraculous things but in the long run could be very harmful,” Solar-Lezama said.

The morning session concluded with an excerpt from the 1925 science fiction novel “Metropolis,” read by senior Joy Ma, a physics and theater arts major, followed by a roundtable discussion on the future of generative AI. The discussion included Joshua Tenenbaum, a professor in the Department of Brain and Cognitive Sciences and a member of CSAIL; Dina Katabi, the Thuan and Nicole Pham Professor in EECS and a principal investigator in CSAIL and the MIT Jameel Clinic; and Max Tegmark, professor of physics; and was moderated by Daniela Rus.

One focus of the discussion was the possibility of developing generative AI models that can go beyond what we can do as humans, such as tools that can sense someone’s emotions by using electromagnetic signals to understand how a person’s breathing and heart rate are changing.

But one key to integrating AI like this into the real world safely is to ensure that we can trust it, Tegmark said. If we know an AI tool will meet the specifications we insist on, then “we no longer have to be afraid of building really powerful systems that go out and do things for us in the world,” he said.

Ariel Furst and Fan Wang receive 2023 National Institutes of Health awards

by MIT School of Science |

The National Institutes of Health (NIH) has awarded grants to MIT’s Ariel Furst and Fan Wang, through its High-Risk, High-Reward Research program. The NIH High-Risk, High-Reward Research program awarded 85 new research grants to support exceptionally creative scientists pursuing highly innovative behavioral and biomedical research projects.

Ariel Furst was selected as the recipient of the NIH Director’s New Innovator Award, which has supported unusually innovative research since 2007. Recipients are early-career investigators who are within 10 years of their final degree or clinical residency and have not yet received a research project grant or equivalent NIH grant.

Furst, the Paul M. Cook Career Development Assistant Professor of Chemical Engineering at MIT, invents technologies to improve human and environmental health by increasing equitable access to resources. Her lab develops transformative technologies to solve problems related to health care and sustainability by harnessing the inherent capabilities of biological molecules and cells. She is passionate about STEM outreach and increasing the participation of underrepresented groups in engineering.

After completing her PhD at Caltech, where she developed noninvasive diagnostics for colorectal cancer, Furst became an A. O. Beckman Postdoctoral Fellow at the University of California at Berkeley. There she developed sensors to monitor environmental pollutants. In 2022, Furst was awarded the MIT UROP Outstanding Faculty Mentor Award for her work with undergraduate researchers. She is a now a 2023 Marion Milligan Mason Awardee, a CIFAR Azrieli Global Scholar for Bio-Inspired Solar Energy, and an ARO Early Career Grantee. She is also a co-founder of the regenerative agriculture company, Seia Bio.

Fan Wang received the Pioneer Award, which has been challenging researchers at all career levels to pursue new directions and develop groundbreaking, high impact approaches to a broad area of biomedical and behavioral sciences since 2004.

Wang, a professor in the Department of Brain and Cognitive Sciences and an investigator in the McGovern Institute for Brain Research, is uncovering the neural circuit mechanisms that govern bodily sensations, like touch, pain, and posture, as well as the mechanisms that control sensorimotor behaviors. Researchers in the Wang lab aim to generate an integrated understanding of the sensation-perception-action process, hoping to find better treatments for diseases like chronic pain, addiction, and movement disorders. Wang’s lab uses genetic, viral, in vivo large-scale electrophysiology and imaging techniques to gain traction in these pursuits.

Wang obtained her PhD at Columbia University, working with Professor Richard Axel. She conducted her postdoctoral work at Stanford University with Mark Tessier-Lavigne, and then subsequently joined Duke University as faculty in 2003. Wang was later appointed as the Morris N. Broad Distinguished Professor of Neurobiology at the Duke University School of Medicine. In January 2023, she joined the faculty of the MIT School of Science and the McGovern Institute.

The High-Risk, High-Reward Research program is funded through the NIH Common Fund, which supports a series of exceptionally high-impact programs that cross NIH Institutes and Centers.

“The HRHR program is a pillar for innovation here at NIH, providing support to transformational research, with advances in biomedical and behavioral science,” says Robert W. Eisinger, acting director of the Division of Program Coordination, Planning, and Strategic Initiatives, which oversees the NIH Common Fund. “These awards align with the Common Fund’s mandate to support science expected to have exceptionally high and broadly applicable impact.”

NIH issued eight Pioneer Awards, 58 New Innovator Awards, six Transformative Research Awards, and 13 Early Independence Awards in 2023. Funding for the awards comes from the NIH Common Fund; the National Institute of General Medical Sciences; the National Institute of Mental Health; the National Library of Medicine; the National Institute on Aging; the National Heart, Lung, and Blood Institute; and the Office of Dietary Supplements.

Twelve with MIT ties elected to the National Academy of Medicine for 2023

by MIT School of Science |

The National Academy of Medicine announced the election of 100 new members to join their esteemed ranks in 2023, among them five MIT faculty members and seven additional affiliates.

MIT professors Daniel Anderson, Regina Barzilay, Guoping Feng, Darrell Irvine, and Morgen Shen were among the new members. Justin Hanes PhD ’96, Said Ibrahim MBA ’16, and Jennifer West ’92, along with three former students in the Harvard-MIT Program in Health Sciences and Technology (HST) — Michael Chiang, Siddhartha Mukherjee, and Robert Vonderheide — were also elected, as was Yi Zhang, an associate member of The Broad Institute of MIT and Harvard.

Election to the academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service, the academy noted in announcing the election of its new members.

MIT faculty

Daniel G. Anderson, professor in the Department of Chemical Engineering and the Institute for Medical Engineering and Science, was elected “for pioneering the area of non-viral gene therapy and cellular delivery. His work has resulted in fundamental scientific advances; over 500 papers, patents, and patent applications; and the creation of companies, products, and technologies that are now in the clinic.” Anderson is an affiliate of the Broad Institute of MIT and Harvard and of the Ragon Institute at MGH, MIT and Harvard.

Regina Barzilay, the School of Engineering Distinguished Professor for AI and Health within the Department of Electrical Engineering and Computer Science at MIT, was elected “for the development of machine learning tools that have been transformational for breast cancer screening and risk assessment, and for the development of molecular design tools broadly utilized for drug discovery.” Barzilay is the AI faculty lead within the MIT Abdul Latif Jameel Clinic for Machine Learning in Health and an affiliate of the Computer Science and Artificial Intelligence Laboratory and Institute for Medical Engineering and Science.

Guoping Feng, the associate director of the McGovern Institute for Brain Research, James W. (1963) and Patricia T. Professor of Neuroscience in MIT’s Department of Brain and Cognitive Sciences, and an affiliate of the Broad Institute of MIT and Harvard, was elected “for his breakthrough discoveries regarding the pathological mechanisms of neurodevelopmental and psychiatric disorders, providing foundational knowledges and molecular targets for developing effective therapeutics for mental illness such as OCD, ASD, and ADHD.”

Darrell J. Irvine ’00, the Underwood-Prescott Professor of Biological Engineering and Materials Science at MIT and a member of the Koch Institute for Integrative Cancer Research, was elected “for the development of novel methods for delivery of immunotherapies and vaccines for cancer and infectious diseases.”

Morgan Sheng, professor of neuroscience in the Department of Brain and Cognitive Sciences, with affiliations in the McGovern Institute and The Picower Institute for Learning and Memory at MIT, as well as the Broad Institute of MIT and Harvard, was elected “for transforming the understanding of excitatory synapses. He revealed the postsynaptic density as a protein network controlling synaptic signaling and morphology; established the paradigm of signaling complexes organized by PDZ scaffolds; and pioneered the concept of localized regulation of mitochondria, apoptosis, and complement for targeted synapse elimination.”

Additional MIT affiliates

Michael F. Chiang, a former student in the Harvard-MIT Program in Health Sciences and Technology (HST) who is now director of the National Eye Institute of the National Institutes of Health, was honored “for pioneering applications of biomedical informatics to ophthalmology in artificial intelligence, telehealth, pediatric retinal disease, electronic health records, and data science, including methodological and diagnostic advances in AI for pediatric retinopathy of prematurity, and for contributions to developing and implementing the largest ambulatory care registry in the United States.”

Justin Hanes PhD ’96, who earned his PhD from the MIT Department of Chemical Engineering and is now a professor at Johns Hopkins University, was honored “for pioneering discoveries and inventions of innovative drug delivery technologies, especially mucosal, ocular, and central nervous system drug delivery systems; and for international leadership in research and education at the interface of engineering, medicine, and entrepreneurship, leading to clinical translation of drug delivery technologies.”

Said Ibrahim MBA ’16, a graduate of the MIT Sloan School of Management who is now a senior vice president and chair, department of medicine at the Zucker School of Medicine at Hofstra/Northwell, was honored for influential “health services research on racial disparities in elective joint replacement that has provided a national model for advancing health equity research beyond the identification of inequities and toward their remediation, and for his research that has been leveraged to engage diverse and innovative emerging scholars.”

Siddhartha Mukherjee, a former student in HST who is now an associate professor of medicine at Columbia University School of Medicine, was honored “for contributing important research in the immunotherapy of myeloid malignancies, such as acute myeloid leukemia, for establishing international centers for immunotherapy for childhood cancers, and for the discovery of tissue-resident stem cells.”

Robert H. Vonderheide, a former student in HST who is now a professor and vice dean at the Perelman School of Medicine and vice president of cancer programs at the University of Pennsylvania Health System, was honored “for developing immune combination therapies for patients with pancreatic cancer by driving proof-of-concept from lab to clinic, then leading national, randomized clinical trials for therapy, maintenance, and interception; and for improving access of minority individuals to clinical trials while directing an NCI comprehensive cancer center.”

Jennifer West ’92, a graduate of the MIT Department of Chemical Engineering who is now a professor of biomedical engineering and dean of the School of Engineering and Applied Science at the University of Virginia at Charlottesville, was honored “for the invention, development, and translation of novel biomaterials including bioactive, photopolymerizable hydrogels and theranostic nanoparticles.”

Yi Zhang, associate member of the Broad Institute, was honored “for making fundamental contributions to the epigenetics field through systematic identification and characterization of chromatin modifying enzymes, including EZH2, JmjC, and Tet. His proof-of-principle work on EZH2 inhibitors led to the founding of Epizyme and eventual making of tazemetostat, a drug approved for epithelioid sarcoma and follicular lymphoma.”

“It is my honor to welcome this truly exceptional class of new members to the National Academy of Medicine,” said NAM President Victor J. Dzau. “Their contributions to health and medicine are unparalleled, and their leadership and expertise will be essential to helping the NAM tackle today’s urgent health challenges, inform the future of health care, and ensure health equity for the benefit of all around the globe.”

Four McGovern Investigators receive NIH BRAIN Initiative grants

by Julie Pryor |

In the human brain, 86 billion neurons form more than 100 trillion connections with other neurons at junctions called synapses. Scientists at the McGovern Institute are working with their collaborators to develop technologies to map these connections across the brain, from mice to humans.

Today, the National Institutes of Health (NIH) announced a new program to support research projects that have the potential to reveal an unprecedented and dynamic picture of the connected networks in the brain. Four of these NIH-funded research projects will take place in McGovern labs.

BRAIN Initiative

In 2013, the Obama administration announced the Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, a public-private research effort to support the development and application of new technologies to understand brain function.

Today, the NIH announced its third project supported by the BRAIN Initiative, called BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS). The new project complements two previous large-scale projects, which together aim to transform neuroscience research by generating wiring diagrams that can span entire brains across multiple species. These detailed wiring diagrams can help uncover the logic of the brain’s neural code, leading to a better understanding of how this circuitry makes us who we are and how it could be rewired to treat brain diseases.

BRAIN CONNECTS at McGovern

The initial round of BRAIN CONNECTS awards will support researchers at more than 40 university and research institutions across the globe with 11 grants totaling $150 million over five years. Four of these grants have been awarded to McGovern researchers Guoping Feng, Ila Fiete, Satra Ghosh, and Ian Wickersham, whose projects are outlined below:

BRAIN CONNECTS: Comprehensive regional projection map of marmoset with single axon and cell type resolution
Team: Guoping Feng (McGovern Institute, MIT), Partha Mitra (Cold Spring Harbor Laboratory), Xiao Wang (Broad Institute), Ian Wickersham (McGovern Institute, MIT)

Summary: This project will establish an integrated experimental-computational platform to create the first comprehensive brain-wide mesoscale connectivity map in a non-human primate (NHP), the common marmoset (Callithrix jacchus). It will do so by tracing axonal projections of RNA barcode-identified neurons brain-wide in the marmoset, utilizing a sequencing-based imaging method that also permits simultaneous transcriptomic cell typing of the identified neurons. This work will help bridge the gap between brain-wide mesoscale connectivity data available for the mouse from a decade of mapping efforts using modern techniques and the absence of comparable data in humans and NHPs.

BRAIN CONNECTS: A center for high-throughput integrative mouse connectomics
Team: Jeff Lichtman (Harvard University), Ila Fiete (McGovern Institute, MIT), Sebastian Seung (Princeton University), David Tank (Princeton University), Hongkui Zeng (Allen Institute), Viren Jain (Google), Greg Jeffries (Oxford University)

Summary: This project aims to produce a large-scale synapse-level brain map (connectome) that includes all the main areas of the mouse hippocampus. This region is of clinical interest because it is an essential part of the circuit underlying spatial navigation and memory and the earliest impairments and degeneration related to Alzheimer’s disease.

BRAIN CONNECTS: The center for Large-scale Imaging of Neural Circuits (LINC)
Team: Anastasia Yendiki (MGH), Satra Ghosh (McGovern, MIT), Suzanne Haber (University of Rochester), Elizabeth Hillman (Columbia University)

Summary: This project will generate connectional diagrams of the monkey and human brain at unprecedented resolutions. These diagrams will be linked both to the neuroanatomic literature and to in vivo neuroimaging techniques, bridging between the rigor of the former and the clinical relevance of the latter. The data to be generated by this project will advance our understanding of brain circuits that are implicated in motor and psychiatric disorders, and that are targeted by deep-brain stimulation to treat these disorders.

BRAIN CONNECTS: Mapping brain-wide connectivity of neuronal types using barcoded connectomics
Team: Xiaoyin Chen (Allen Institute), Ian Wickersham (McGovern Institute, MIT), and Justus Kebschull of JHU

Summary: This project aims to optimize and develop barcode sequencing-based neuroanatomical techniques to achieve brain-wide, high-throughput, highly multiplexed mapping of axonal projections and synaptic connectivity of neuronal types at cellular resolution in primate brains. The team will work together to apply these techniques to generate an unprecedented multi-resolution map of brain-wide projections and synaptic inputs of neurons in the macaque visual cortex at cellular resolution.

 

Nuevo podcast de neurociencia en español celebra su tercera temporada

by Thea Singer |

Sylvia Abente, neuróloga clínica de la Universidad Nacional de Asunción (Paraguay), investiga la variedad de síntomas que son característicos de la epilepsia. Trabaja con los pueblos indígenas de Paraguay, y su dominio del español y el guaraní, los dos idiomas oficiales de Paraguay, le permite ayudar a los pacientes a encontrar las palabras que ayuden a describir sus síntomas de epilepsia para poder tratarlos.

Juan Carlos Caicedo Mera, neurocientífico de la Universidad Externado de Colombia, utiliza modelos de roedores para investigar los efectos neurobiológicos del estrés en los primeros años de vida. Ha desempeñado un papel decisivo en despertar la conciencia pública sobre los efectos biológicos y conductuales del castigo físico a edades tempranas, lo que ha propiciado cambios políticos encaminados a reducir su prevalencia como práctica cultural en Colombia.

Woman interviews a man at a table with a camera recording the interview in the foreground.
Jessica Chomik-Morales (right) interviews Pedro Maldonado at the Biomedical Neuroscience Institute of Chile at the University of Chile. Photo: Jessica Chomik-Morales

Estos son solo dos de los 33 neurocientíficos de siete países latinoamericanos que Jessica Chomik-Morales entrevistó durante 37 días para la tercera temporada de su podcast en español “Mi Última Neurona,” que se estrenará el 18 de septiembre a las 5:00 p. m. en YouTube. Cada episodio dura entre 45 y 90 minutos.

“Quise destacar sus historias para disipar la idea errónea de que la ciencia de primer nivel solo puede hacerse en Estados Unidos y Europa,” dice Chomik-Morales, “o que no se consigue en Sudamérica debido a barreras financieras y de otro tipo.”

Chomik-Morales, graduada universitaria de primera generación que creció en Asunción (Paraguay) y Boca Ratón (Florida), es ahora investigadora académica de post licenciatura en el MIT. Aquí trabaja con Laura Schulz, profesora de Ciencia Cognitiva, y Nancy Kanwisher, investigadora del McGovern Institute y la profesora Walter A. Rosenblith de Neurociencia Cognitiva, utilizando imágenes cerebrales funcionales para investigar de qué forma el cerebro explica el pasado, predice el futuro e interviene sobre el presente a traves del razonamiento causal.

“El podcast está dirigido al público en general y es apto para todas las edades,” afirma. “Se explica la neurociencia de forma fácil para inspirar a los jóvenes en el sentido de que ellos también pueden llegar a ser científicos y para mostrar la amplia variedad de investigaciones que se realizan en los países de origen de los escuchas.”

El viaje de toda una vida

“Mi Última Neurona” comenzó como una idea en 2021 y creció rápidamente hasta convertirse en una serie de conversaciones con destacados científicos hispanos, entre ellos L. Rafael Reif, ingeniero electricista venezolano-estadounidense y 17.º presidente del MIT.

Woman interviews man at a table while another man adjusts microphone.
Jessica Chomik-Morales (left) interviews the 17th president of MIT, L. Rafael Reif (right), for her podcast while Héctor De Jesús-Cortés (center) adjusts the microphone. Photo: Steph Stevens

Con las relaciones profesionales que estableció en las temporadas uno y dos, Chomik-Morales amplió su visión y reunió una lista de posibles invitados en América Latina para la tercera temporada. Con la ayuda de su asesor científico, Héctor De Jesús-Cortés, un investigador Boricua de posdoctorado del MIT, y el apoyo financiero del McGovern Institute, el Picower Institute for Learning and Memory, el Departamento de Ciencias Cerebrales y Cognitivas, y las Iniciativas Internacionales de Ciencia y Tecnología del MIT, Chomik-Morales organizó entrevistas con científicos en México, Perú, Colombia, Chile, Argentina, Uruguay y Paraguay durante el verano de 2023.

Viajando en avión cada cuatro o cinco días, y consiguiendo más posibles participantes de una etapa del viaje a la siguiente por recomendación, Chomik-Morales recorrió más de 10,000 millas y recopiló 33 historias para su tercera temporada. Las áreas de especialización de los científicos abarcan toda una variedad de temas, desde los aspectos sociales de los ciclos de sueño y vigilia hasta los trastornos del estado de ánimo y la personalidad, pasando por la lingüística y el lenguaje en el cerebro o el modelado por computadoras como herramienta de investigación.

“Si alguien estudia la depresión y la ansiedad, quiero hablar sobre sus opiniones con respecto a diversas terapias, incluidos los fármacos y también las microdosis con alucinógenos,” dice Chomik-Morales. “Estas son las cosas de las que habla la gente.” No le teme a abordar temas delicados, como la relación entre las hormonas y la orientación sexual, porque “es importante que la gente escuche a los expertos hablar de estas cosas,” comenta.

El tono de las entrevistas va de lo informal (“el investigador y yo somos como amigos”, dice) a lo pedagógico (“de profesor a alumno”). Lo que no cambia es la accesibilidad (se evitan términos técnicos) y las preguntas iniciales y finales en cada entrevista. Para empezar: “¿Cómo ha llegado hasta aquí? ¿Qué le atrajo de la neurociencia?”. Para terminar: “¿Qué consejo le daría a un joven estudiante latino interesado en Ciencias, Ingeniería, Tecnología y Matemáticas[1]?

Permite que el marco de referencia de sus escuchas sea lo que la guíe. “Si no entendiera algo o pensara que se podría explicar mejor, diría: ‘Hagamos una pausa’. ¿Qué significa esta palabra?”, aunque ella conociera la definición. Pone el ejemplo de la palabra “MEG” (magnetoencefalografía): la medición del campo magnético generado por la actividad eléctrica de las neuronas, que suele combinarse con la resonancia magnética para producir imágenes de fuentes magnéticas. Para aterrizar el concepto, preguntaría: “¿Cómo funciona? ¿Este tipo de exploración hace daño al paciente?”.

Allanar el camino para la creación de redes globales

El equipo de Chomik-Morales era escaso: tres micrófonos Yeti y una cámara de video Canon conectada a su computadora portátil. Las entrevistas se realizaban en salones de clase, oficinas universitarias, en la casa de los investigadores e incluso al aire libre, ya que no había estudios insonorizados disponibles. Ha estado trabajando con el ingeniero de sonido David Samuel Torres, de Puerto Rico, para obtener un sonido más claro.

Ninguna limitación tecnológica podía ocultar la importancia del proyecto para los científicos participantes.

Two women talking at a table in front of a camera.
Jessica Chomik-Morales (left) interviews Josefina Cruzat (right) at Adolfo Ibañez University in Chile. Photo: Jessica Chomik-Morales

“Mi Última Neurona” muestra nuestro conocimiento diverso en un escenario global, proporcionando un retrato más preciso del panorama científico en América Latina,” dice Constanza Baquedano, originaria de Chile. “Es un avance hacia la creación de una representación más inclusiva en la ciencia”. Baquendano es profesora adjunta de psicología en la Universidad Adolfo Ibáñez, en donde utiliza electrofisiología y mediciones electroencefalográficas y conductuales para investigar la meditación y otros estados contemplativos. “Estaba ansiosa por ser parte de un proyecto que buscara brindar reconocimiento a nuestras experiencias compartidas como mujeres latinoamericanas en el campo de la neurociencia.”

“Comprender los retos y las oportunidades de los neurocientíficos que trabajan en América Latina es primordial,” afirma Agustín Ibáñez, profesor y director del Instituto Latinoamericano de Salud Cerebral (BrainLat) de la Universidad Adolfo Ibáñez de Chile. “Esta región, que se caracteriza por tener importantes desigualdades que afectan la salud cerebral, también presenta desafíos únicos en el campo de la neurociencia,” afirma Ibáñez, quien se interesa principalmente en la intersección de la neurociencia social, cognitiva y afectiva. “Al centrarse en América Latina, el podcast da a conocer las historias que frecuentemente no se cuentan en la mayoría de los medios. Eso tiende puentes y allana el camino para la creación de redes globales.”

Por su parte, Chomik-Morales confía en que su podcast generará un gran número de seguidores en América Latina. “Estoy muy agradecida por el espléndido patrocinio del MIT,” dice Chomik-Morales. “Este es el proyecto más gratificante que he hecho en mi vida.”

__

[1] En inglés Science, Technology, Engineering and Mathematics (STEM)

New Spanish-language neuroscience podcast flourishes in third season

by Thea Singer |

A Spanish version of this news story can be found here. (Una versión en español de esta noticia se puede encontrar aquí.)

___

Sylvia Abente, a clinical neurologist at the Universidad Nacional de Asunción in Paraguay, investigates the range of symptoms that characterize epilepsy. She works with indigenous peoples in Paraguay, and her fluency in Spanish and Guarni—the two official languages of Paraguay—allows her to help patients find the words to describe their epilepsy symptoms so she can treat them.

Juan Carlos Caicedo Mera, a neuroscientist at the Universidad Externado de Colombia, uses rodent models to research the neurobiological effects of early life stress. He has been instrumental in raising public awareness about the biological and behavioral effects of early-age physical punishment, leading to policy changes aimed at reducing its prevalence as a cultural practice in Colombia.

Woman interviews a man at a table with a camera recording the interview in the foreground.
Jessica Chomik-Morales (right) interviews Pedro Maldonado at the Biomedical Neuroscience Institute of Chile at the University of Chile. Photo: Jessica Chomik-Morales

Those are just two of the 33 neuroscientists in seven Latin American countries that Jessica Chomik-Morales interviewed over 37 days for the expansive third season of her Spanish-language podcast, “Mi Ultima Neurona” (“My Last Neuron”), which launches Sept. 18 at 5 p.m. on YouTube. Each episode runs between 45 and 90 minutes.

“I wanted to shine a spotlight on their stories to dispel the misconception that excellent science can only be done in America and Europe,” says Chomik-Morales, “or that it isn’t being produced in South America because of financial and other barriers.”

A first-generation college graduate who grew up in Asunción, Paraguay and Boca Raton, Florida, Chomik-Morales is now a postbaccalaureate research scholar at MIT. Here she works with Laura Schulz, professor of cognitive science, and Nancy Kanwisher, McGovern Institute investigator and the Walter A. Rosenblith Professor of Cognitive Neuroscience, using functional brain imaging to investigate how the brain explains the past, predicts the future, and intervenes on the present.

“The podcast is for the general public and is suitable for all ages,” she says. “It explains neuroscience in a digestable way to inspire young people that they, too, can become scientists and to show the rich variety of reseach that is being done in listeners’ home countries.”

Journey of a lifetime

“Mi Ultima Neurona” began as an idea in 2021 and grew rapidly into a collection of conversations with prominent Hispanic scientists, including L. Rafael Reif, a Venezuelan-American electrical engineer and the 17th president of MIT.

Woman interviews man at a table while another man adjusts microphone.
Jessica Chomik-Morales (left) interviews the 17th president of MIT, L. Rafael Reif (right), for her podcast while Héctor De Jesús-Cortés (center) adjusts the microphone. Photo: Steph Stevens

Building upon the professional relationships she built in seasons one and two, Chomik-Morales broadened her vision, and assembled a list of potential guests in Latin America for season three.  With research help from her scientific advisor, Héctor De Jesús-Cortés, an MIT postdoc from Puerto Rico, and financial support from the McGovern Institute, the Picower Institute for Learning and Memory, the Department of Brain and Cognitive Sciences, and MIT International Science and Technology Initiatives, Chomik-Morales lined up interviews with scientists in Mexico, Peru, Colombia, Chile, Argentina, Uruguay, and Paraguay during the summer of 2023.

Traveling by plane every four or five days, and garnering further referrals from one leg of the trip to the next through word of mouth, Chomik-Morales logged over 10,000 miles and collected 33 stories for her third season. The scientists’ areas of specialization run the gamut— from the social aspects of sleep/wake cycles to mood and personality disorders, from linguistics and language in the brain to computational modeling as a research tool.

“This is the most fulfilling thing I’ve ever done.” – Jessica Chomik-Morales

“If somebody studies depression and anxiety, I want to touch on their opinions regarding various therapies, including drugs, even microdosing with hallucinogens,” says Chomik-Morales. “These are the things people are talking about.” She’s not afraid to broach sensitive topics, like the relationship between hormones and sexual orientation, because “it’s important that people listen to experts talk about these things,” she says.

The tone of the interviews range from casual (“the researcher and I are like friends,” she says) to pedagogic (“professor to student”). The only constants are accessibility—avoiding technical terms—and the opening and closing questions in each one. To start: “How did you get here? What drew you to neuroscience?” To end: “What advice would you give a young Latino student who is interested in STEM?”

She lets her listeners’ frame of reference be her guide. “If I didn’t understand something or thought it could be explained better, I’d say, ‘Let’s pause. ‘What does this word mean?’ ” even if she knew the definition herself. She gives the example of the word “MEG” (magnetoencephalography)—the measurement of the magnetic field generated by the electrical activity of neurons, which is usually combined with magnetic resonance imaging to produce magnetic source imaging. To bring the concept down to Earth, she’d ask: “How does it work? Does this kind of scan hurt the patient?’ ”

Paving the way for global networking

Chomik-Morales’s equipment was spare: three Yeti microphones and a Canon video camera connected to her laptop computer. The interviews took place in classrooms, university offices, at researchers’ homes, even outside—no soundproof studios were available. She has been working with sound engineer David Samuel Torres, from Puerto Rico, to clarify the audio.

No technological limitations could obscure the significance of the project for the participating scientists.

Two women talking at a table in front of a camera.
Jessica Chomik-Morales (left) interviews Josefina Cruzat (right) at Adolfo Ibañez University in Chile. Photo: Jessica Chomik-Morales

“‘Mi Ultima Neurona’ showcases our diverse expertise on a global stage, providing a more accurate portrayal of the scientific landscape in Latin America,” says Constanza Baquedano, who is from Chile. “It’s a step toward creating a more inclusive representation in science.” Baquendano is an assistant professor of psychology at Universidad Adolfo Ibáñez, where she uses electrophysiology and electroencephalographic and behavioral measurements to investigate meditation and other contemplative states. “I was eager to be a part of a project that aimed to bring recognition to our shared experiences as Latin American women in the field of neuroscience.”

“Understanding the challenges and opportunities of neuroscientists working in Latin America is vital,”says Agustín Ibañez, professor and director of the Latin American Brain Health Institute (BrainLat) at Universidad Adolfo Ibáñez in Chile. “This region, characterized by significant inequalities affecting brain health, also presents unique challenges in the field of neuroscience,” says Ibañez, who is primarily interested in the intersection of social, cognitive, and affective neuroscience. “By focusing on Latin America, the podcast brings forth the narratives that often remain untold in the mainstream. That bridges gaps and paves the way for global networking.”

For her part, Chomik-Morales is hopeful that her podcast will generate a strong following in Latin America. “I am so grateful for the wonderful sponsorship from MIT,” says Chomik-Morales. “This is the most fulfilling thing I’ve ever done.”